JERUSALEM, Nov. 12, 2012 /PRNewswire/ -- IDenta Corp. (OTC Pink: IDTA) CEO Yaacov Shoham today announced the following update to the IDenta Touch&Know marketing program through the drug store chain.
Mr. Shoham commented, "In order to make the Touch&Know Discreet drug test kits well known in the community, a discount coupon program was started on October 28 and will continue until the end of November."
The kits are available at the largest drug store chain in the United States and the link to the coupon is:
Mr. Shoham also stated, "Sales of the kits have been very good since the product was placed on the shelves (end of September 2012) and new orders have been received every week since then.
In addition to the first order, orders totaling $110,000 have been received from the drug store chain."
IDenta's entire product line may be found at www.IDenta-corp.com, www.drugsdetector.com and www.IDenta.biz
Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, email@example.com, www.drugsdetector.comwww.identa.bizwww.identa-corp.com
Yaacov Shoham CEO
SOURCE IDenta Corp.